| Rituximab for severe membranous nephropathy: a 6-month trial with extended follow-up K Dahan, H Debiec, E Plaisier, M Cachanado, A Rousseau, L Wakselman, ... Journal of the American Society of Nephrology 28 (1), 348-358, 2017 | 410 | 2017 |
| Improved survival of critically ill cancer patients with septic shock J Larché, É Azoulay, F Fieux, L Mesnard, D Moreau, G Thiery, M Darmon, ... Intensive care medicine 29, 1688-1695, 2003 | 332 | 2003 |
| Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis G Bollée, M Flamant, S Schordan, C Fligny, E Rumpel, M Milon, ... Nature medicine 17 (10), 1242-1250, 2011 | 257 | 2011 |
| Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin ii–induced hypertension E Letavernier, J Perez, A Bellocq, L Mesnard, A de Castro Keller, ... Circulation research 102 (6), 720-728, 2008 | 187 | 2008 |
| Early epithelial phenotypic changes predict graft fibrosis A Hertig, D Anglicheau, N Pallet, M Touzot, PY Ancel, L Mesnard, ... Journal of the American Society of Nephrology 19 (8), 1584-1591, 2008 | 184 | 2008 |
| Autoantibodies specific for the phospholipase A2 receptor in recurrent and de novo membranous nephropathy H Debiec, L Martin, C Jouanneau, G Dautin, L Mesnard, E Rondeau, ... American Journal of Transplantation 11 (10), 2144-2152, 2011 | 178 | 2011 |
| The Ets-1 transcription factor controls the development and function of natural regulatory T cells E Mouly, K Chemin, HV Nguyen, M Chopin, L Mesnard, ... Journal of Experimental Medicine 207 (10), 2113-2125, 2010 | 154 | 2010 |
| Vancomycin-associated cast nephropathy Y Luque, K Louis, C Jouanneau, S Placier, E Esteve, D Bazin, E Rondeau, ... Journal of the American Society of Nephrology 28 (6), 1723-1728, 2017 | 146 | 2017 |
| Reducing T imp3 or vitronectin ameliorates disease manifestations in CADASIL mice C Capone, E Cognat, L Ghezali, C Baron‐Menguy, D Aubin, L Mesnard, ... Annals of neurology 79 (3), 387-403, 2016 | 98 | 2016 |
| The IgA1 immune complex–mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy H Tamouza, JM Chemouny, LR Kafkova, L Berthelot, M Flamant, ... Kidney international 82 (12), 1284-1296, 2012 | 98 | 2012 |
| Genetic inhibition of discoidin domain receptor 1 protects mice against crescentic glomerulonephritis M Kerroch, D Guerrot, S Vandermeersch, S Placier, L Mesnard, ... The FASEB Journal 26 (10), 4079-4091, 2012 | 85 | 2012 |
| Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice D Cathelin, S Placier, M Ploug, MC Verpont, S Vandermeersch, Y Luque, ... Journal of the American Society of Nephrology 25 (8), 1662-1668, 2014 | 79 | 2014 |
| Report of the inefficacy of eculizumab in two cases of severe antibody-mediated rejection of renal grafts M Burbach, C Suberbielle, I Brochériou, C Ridel, L Mesnard, K Dahan, ... Transplantation 98 (10), 1056-1059, 2014 | 78 | 2014 |
| The tetraspanin CD9 controls migration and proliferation of parietal epithelial cells and glomerular disease progression H Lazareth, C Henique, O Lenoir, VG Puelles, M Flamant, G Bollée, ... Nature communications 10 (1), 3303, 2019 | 73 | 2019 |
| Aortic stiffness of kidney transplant recipients correlates with donor age M Delahousse, M Chaignon, L Mesnard, P Boutouyrie, ME Safar, T Lebret, ... Journal of the American Society of Nephrology 19 (4), 798-805, 2008 | 71 | 2008 |
| Genetic and pharmacological inhibition of microRNA-92a maintains podocyte cell cycle quiescence and limits crescentic glomerulonephritis C Henique, G Bollée, X Loyer, F Grahammer, N Dhaun, M Camus, ... Nature communications 8 (1), 1829, 2017 | 67 | 2017 |
| Exome sequencing and prediction of long-term kidney allograft function L Mesnard, T Muthukumar, M Burbach, C Li, H Shang, D Dadhania, ... PLoS computational biology 12 (9), e1005088, 2016 | 65 | 2016 |
| Invariant natural killer T cells and TGF-β attenuate anti-GBM glomerulonephritis L Mesnard, ADC Keller, ML Michel, S Vandermeersch, E Letavernier, ... Journal of the American Society of Nephrology 20 (6), 1282-1292, 2009 | 64 | 2009 |
| Antibiotics versus no therapy in kidney transplant recipients with asymptomatic bacteriuria (BiRT): a pragmatic, multicentre, randomized, controlled trial J Coussement, N Kamar, M Matignon, L Weekers, A Scemla, M Giral, ... Clinical microbiology and infection 27 (3), 398-405, 2021 | 62 | 2021 |
| Novel insights into non‐HLA alloimmunity in kidney transplantation R Reindl‐Schwaighofer, A Heinzel, GA Gualdoni, L Mesnard, FHJ Claas, ... Transplant International 33 (1), 5-17, 2020 | 53 | 2020 |
